Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Chyi Pai

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Dementia and Geriatric Cognitive Disorders Extra|October 6, 2016
Clinical Recommendations for the Use of Donepezil 23 mg in Moderate-to-Severe Alzheimer's Disease in the Asia-Pacific RegionMarwan Sabbagh, SeolHeui Han, SangYun Kim, et al.
Diagnostics (Basel, Switzerland)|February 24, 2024
Classification Prediction of Alzheimer's Disease and Vascular Dementia Using Physiological Data and ECD SPECT ImagesYu-Ching Ni, Zhi-Kun Lin, Chen-Han Cheng, et al.
Scientific Reports|January 25, 2022
Evidence of plasma biomarkers indicating high risk of dementia in cognitively normal subjectsMing-Chyi Pai, Chau-Chung Wu, Yi-Chou Hou, et al.
Annals of Nuclear Medicine|June 2, 2021
Detection of Alzheimer's disease using ECD SPECT images by transfer learning from FDG PETYu-Ching Ni, Fan-Pin Tseng, Ming-Chyi Pai, et al.
The Lancet Regional Health. Western Pacific|October 14, 2024
Dementia diagnostic and treatment services in the Western Pacific: challenges, preparedness and opportunities in the face of amyloid-targeting therapiesClaire O'Callaghan, Johannes C Michaelian, Yoko Aihara, et al.
The Lancet Regional Health. Western Pacific|December 6, 2024
Corrigendum to "Dementia diagnostic and treatment services in the Western Pacific: challenges, preparedness and opportunities in the face of amyloid-targeting therapies" [The Lancet Regional Health-Western Pacific, Volume 50, September 2024, 101183]Claire O'Callaghan, Johannes C Michaelian, Yoko Aihara, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 31, 2024
Application of blood-based biomarkers of Alzheimer's disease in clinical practice: Recommendations from Taiwan Dementia SocietyYu-Wen Cheng, Yen-Ju Lin, Yung-Shuan Lin, et al.
Diagnostics (Basel, Switzerland)|November 27, 2021
The Feasibility of Differentiating Lewy Body Dementia and Alzheimer's Disease by Deep Learning Using ECD SPECT ImagesYu-Ching Ni, Fan-Pin Tseng, Ming-Chyi Pai, et al.
Journal of Alzheimer'S Disease Reports|December 6, 2021
Assessment of High Risk for Alzheimer's Disease Using Plasma Biomarkers in Subjects with Normal Cognition in Taiwan: A Preliminary StudyChaur-Jong Hu, Ming-Jang Chiu, Ming-Chyi Pai, et al.
Frontiers in Aging Neuroscience|September 26, 2019
Age-Dependent Relationship Between Plasma Aβ40 and Aβ42 and Total Tau Levels in Cognitively Normal SubjectsLih-Fen Lue, Ming-Chyi Pai, Ta-Fu Chen, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Dementia and Geriatric Cognitive Disorders Extra|October 6, 2016
Clinical Recommendations for the Use of Donepezil 23 mg in Moderate-to-Severe Alzheimer's Disease in the Asia-Pacific RegionMarwan Sabbagh, SeolHeui Han, SangYun Kim, et al.
Diagnostics (Basel, Switzerland)|February 24, 2024
Classification Prediction of Alzheimer's Disease and Vascular Dementia Using Physiological Data and ECD SPECT ImagesYu-Ching Ni, Zhi-Kun Lin, Chen-Han Cheng, et al.
Scientific Reports|January 25, 2022
Evidence of plasma biomarkers indicating high risk of dementia in cognitively normal subjectsMing-Chyi Pai, Chau-Chung Wu, Yi-Chou Hou, et al.
Annals of Nuclear Medicine|June 2, 2021
Detection of Alzheimer's disease using ECD SPECT images by transfer learning from FDG PETYu-Ching Ni, Fan-Pin Tseng, Ming-Chyi Pai, et al.
The Lancet Regional Health. Western Pacific|October 14, 2024
Dementia diagnostic and treatment services in the Western Pacific: challenges, preparedness and opportunities in the face of amyloid-targeting therapiesClaire O'Callaghan, Johannes C Michaelian, Yoko Aihara, et al.
The Lancet Regional Health. Western Pacific|December 6, 2024
Corrigendum to "Dementia diagnostic and treatment services in the Western Pacific: challenges, preparedness and opportunities in the face of amyloid-targeting therapies" [The Lancet Regional Health-Western Pacific, Volume 50, September 2024, 101183]Claire O'Callaghan, Johannes C Michaelian, Yoko Aihara, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 31, 2024
Application of blood-based biomarkers of Alzheimer's disease in clinical practice: Recommendations from Taiwan Dementia SocietyYu-Wen Cheng, Yen-Ju Lin, Yung-Shuan Lin, et al.
Diagnostics (Basel, Switzerland)|November 27, 2021
The Feasibility of Differentiating Lewy Body Dementia and Alzheimer's Disease by Deep Learning Using ECD SPECT ImagesYu-Ching Ni, Fan-Pin Tseng, Ming-Chyi Pai, et al.
Journal of Alzheimer'S Disease Reports|December 6, 2021
Assessment of High Risk for Alzheimer's Disease Using Plasma Biomarkers in Subjects with Normal Cognition in Taiwan: A Preliminary StudyChaur-Jong Hu, Ming-Jang Chiu, Ming-Chyi Pai, et al.
Frontiers in Aging Neuroscience|September 26, 2019
Age-Dependent Relationship Between Plasma Aβ40 and Aβ42 and Total Tau Levels in Cognitively Normal SubjectsLih-Fen Lue, Ming-Chyi Pai, Ta-Fu Chen, et al.
Pageof 9